PlainRecalls
FDA Drug Moderate Class II Terminated

RIBAVIRIN, Capsule, 200 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 68382026007

Reported: January 22, 2014 Initiated: July 2, 2013 #D-727-2014

Product Description

RIBAVIRIN, Capsule, 200 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 68382026007

Reason for Recall

Labeling:Label Mixup; RIBAVIRIN, Capsule, 200 mg may be potentially mislabeled as MODAFINIL, Tablet, 50 mg (1/2 of 100 MG Tablet), NDC 55253080130, Pedigree: AD21787_4, EXP: 5/1/2014; DESIPRAMINE HCL, Tablet, 50 mg, NDC 45963034302, Pedigree: AD30140_7, EXP: 5/7/2014.

Details

Recalling Firm
Aidapak Services, LLC
Units Affected
168 Capsules
Distribution
Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Location
Vancouver, WA

Frequently Asked Questions

What product was recalled?
RIBAVIRIN, Capsule, 200 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 68382026007. Recalled by Aidapak Services, LLC. Units affected: 168 Capsules.
Why was this product recalled?
Labeling:Label Mixup; RIBAVIRIN, Capsule, 200 mg may be potentially mislabeled as MODAFINIL, Tablet, 50 mg (1/2 of 100 MG Tablet), NDC 55253080130, Pedigree: AD21787_4, EXP: 5/1/2014; DESIPRAMINE HCL, Tablet, 50 mg, NDC 45963034302, Pedigree: AD30140_7, EXP: 5/7/2014.
Which agency issued this recall?
This recall was issued by the FDA Drug on January 22, 2014. Severity: Moderate. Recall number: D-727-2014.